価格表

在庫・価格 : 2024年04月30日 20時10分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
FGF23(C-terminal and Intact) Multi-Matrix ELISA Kit (12×8tests)
データシート
BI-20702 BMCバイオメディカ
BIOMEDICA Medizinprodukte GmbH
1 kit ¥156,000
(未発注)
追加

在庫・価格 : 2024年04月30日 20時10分 現在

FGF23(C-terminal and Intact) Multi-Matrix ELISA Kit (12×8tests)

  • 商品コード:BI-20702
  • メーカー:BMC
  • 包装:1kit
  • 価格: ¥156,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Ito E et al. Effect of combined vitamin D receptor activator and lanthanum carbonate on serum fibroblast growth factor 23 level in predialysis patients (CVD-LAF study): design and method. Clin. Exp. Nephrol. 2018 Dec;22(6):1309-1314
Ito E et al
2018/01/01
PubMed
2 Nakayama M et al. Oral Ferric Citrate Hydrate Associated With Less Oxidative Stress Than Intravenous Saccharated Ferric Oxide. Kidney Int Rep 2018 Mar;3(2):364-373
Nakayama M et al
2018/01/01
PubMed
3 Lyngbakken MN et al. Fibroblast growth factor 23 in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study. Clin. Biochem. 2018 Feb;52:41-47
Lyngbakken MN et al
2018/01/01
PubMed
4 Holmlund-Suila E et al. Sex and Iron Modify Fibroblast Growth Factor 23 Concentration in 1-Year-Old Children. J. Clin. Endocrinol. Metab. 2017 12;102(12):4526-4533
Holmlund-Suila E et al
2017/01/01
PubMed
5 Mettang T et al. Fibroblast Growth-factor 23 and Calcium-binding Proteins are not Associated with Chronic Itch in Patients on Haemodialysis. Acta Derm. Venereol. 2017 03;97(3):381-382
Mettang T et al
2017/01/01
PubMed
6 Trummer C et al. Effects of vitamin D supplementation on FGF23: a randomized-controlled trial. Eur J Nutr 2019 Mar;58(2):697-703
Trummer C et al
2019/01/01
PubMed
7 Yamashita K et al. Oral iron supplementation with sodium ferrous citrate reduces the serum intact and c-terminal fibroblast growth factor 23 levels of maintenance haemodialysis patients. Nephrology (Carlton) 2017 Dec;22(12):947-953
Yamashita K et al
2017/01/01
PubMed
8 Goto S et al. Serum FGF23 levels may not be associated with serum phosphate and 1,25-dihydroxyvitamin D levels in patients with Fanconi syndrome-induced hypophosphatemia. Clin Kidney J 2016 Oct;9(5):677-81
Goto S et al
2016/01/01
PubMed
  • No.: 1
  • 文献情報:
    Ito E et al. Effect of combined vitamin D receptor activator and lanthanum carbonate on serum fibroblast growth factor 23 level in predialysis patients (CVD-LAF study): design and method. Clin. Exp. Nephrol. 2018 Dec;22(6):1309-1314
    Ito E et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Nakayama M et al. Oral Ferric Citrate Hydrate Associated With Less Oxidative Stress Than Intravenous Saccharated Ferric Oxide. Kidney Int Rep 2018 Mar;3(2):364-373
    Nakayama M et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Lyngbakken MN et al. Fibroblast growth factor 23 in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study. Clin. Biochem. 2018 Feb;52:41-47
    Lyngbakken MN et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Holmlund-Suila E et al. Sex and Iron Modify Fibroblast Growth Factor 23 Concentration in 1-Year-Old Children. J. Clin. Endocrinol. Metab. 2017 12;102(12):4526-4533
    Holmlund-Suila E et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Mettang T et al. Fibroblast Growth-factor 23 and Calcium-binding Proteins are not Associated with Chronic Itch in Patients on Haemodialysis. Acta Derm. Venereol. 2017 03;97(3):381-382
    Mettang T et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Trummer C et al. Effects of vitamin D supplementation on FGF23: a randomized-controlled trial. Eur J Nutr 2019 Mar;58(2):697-703
    Trummer C et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Yamashita K et al. Oral iron supplementation with sodium ferrous citrate reduces the serum intact and c-terminal fibroblast growth factor 23 levels of maintenance haemodialysis patients. Nephrology (Carlton) 2017 Dec;22(12):947-953
    Yamashita K et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Goto S et al. Serum FGF23 levels may not be associated with serum phosphate and 1,25-dihydroxyvitamin D levels in patients with Fanconi syndrome-induced hypophosphatemia. Clin Kidney J 2016 Oct;9(5):677-81
    Goto S et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed